Bumper Offer - Urjas oil Just @ Rs. 1
Torleva 750 Tablet is a prescription medicine that is available as a Tablet. Epilepsy are some of its major therapeutic uses. Torleva 750 Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Torleva 750 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Common side effects of Torleva 750 Tablet include Fatigue, Headache, Drowsiness. Some other side effects of Torleva 750 Tablet have been listed ahead. Normally, these side effects of Torleva 750 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Torleva 750 Tablet's effect is Moderate during pregnancy and Mild for lactating mothers. In addition, Torleva 750 Tablet's effects on the liver, heart and kidney are discussed below in the Torleva 750 Tablet related warnings section.
The section on Torleva 750 Tablet contraindications lists all such conditions.
Drug reaction of Torleva 750 Tablet with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Torleva 750 Tablet is not safe while driving, and is not addiction.
Torleva 750 Tablet is used to treat the following -
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Torleva 750 Tablet is used -
Moderate
Mild
Common
Is the use of Torleva 750 Tablet safe for pregnant women?
Torleva may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Torleva again without your doctor's advice.
Is the use of Torleva 750 Tablet safe during breastfeeding?
Torleva has been seen to have minimal side effects on breastfeeding women.
What is the effect of Torleva 750 Tablet on the Kidneys?
Torleva rarely affects the kidneys.
What is the effect of Torleva 750 Tablet on the Liver?
Torleva has very mild side effects on the liver.
What is the effect of Torleva 750 Tablet on the Heart?
Torleva is completely safe for the heart.
Torleva 750 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Torleva 750 Tablet unless your doctor advises you to do so -
Is this Torleva 750 Tablet habit forming or addictive?
Forming a habit of Torleva 750 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Torleva 750 Tablet, you should not drive or work on any heavy machine, as Torleva 750 Tablet can make you drowsy.
Is it safe?
Yes, but take Torleva 750 Tablet only as per medical advice.
Is it able to treat mental disorders?
Yes, taking Torleva 750 Tablet can treat mental disorders.
Interaction between Food and Torleva 750 Tablet
Taking Torleva 750 Tablet with food does not harm your health.
Interaction between Alcohol and Torleva 750 Tablet
Consuming Torleva 750 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
